| | | | | |
BDSX Biodesix, Inc. Common Stock | $21,3650 | -0,26% | $227,72M | $58,31K | |
IRAB Iris Acquisition Corp II | $9,9500 | +0,00% | $227,67M | $1,20K | |
REFI Chicago Atlantic Real Estate Finance, Inc. Common Stock | $10,7400 | -0,74% | $227,63M | $107,44K | |
SMTI Sanara MedTech Inc. Common Stock | $24,8650 | +4,39% | $227,63M | $45,60K | |
SABA Saba Capital Income & Opportunities Fund II | $8,2100 | +0,37% | $227,54M | $47,66K | |
CRAC Crown Reserve Acquisition Corp. I Class A Ordinary Shares | $10,1050 | -0,25% | $226,14M | $21,54K | |
NPV Nuveen Virginia Quality Municipal Income Fund | $11,3800 | -0,18% | $225,55M | $31,77K | |
OPBK OP Bancorp Common Stock | $14,9700 | +0,74% | $225,49M | $30,29K | |
PNNT Pennant Investment Corp | $3,4000 | -1,16% | $225,27M | $595,96K | |
AOMR Angel Oak Mortgage REIT, Inc. | $9,0200 | +0,00% | $225,22M | $80,66K | |
| $2,2400 | -7,82% | $224,51M | $530,40K | |
| $6,7600 | +0,15% | $224,42M | $304,16K | |
CHRS Coherus Oncology, Inc. Common Stock | $1,4700 | -4,55% | $223,66M | $459,54K | |
KROS Keros Therapeutics, Inc. Common Stock | $11,1050 | -5,89% | $222,85M | $209,83K | |
QTTB Q32 Bio Inc. Common Stock | $21,3900 | +90,81% | $221,95M | $27,27M | |
